SEC Form 3 · accession 0001213900-26-082796
60 DEGREES PHARMACEUTICALS, INC. · SXTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Knight Therapeutics Inc.
10% Owner
Period of report
Jul 22, 2026
Accepted (ET)
Jul 29, 2026 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001946563
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value per share | holding | — | — | — | 658,629 | D |
Table II — derivative securities
No Table II lines on this filing.